Obstacles to adherence in living with type-2 diabetes: An international qualitative study using meta-ethnography (EUROBSTACLE)

References 

1. Marinker M. From compliance to concordance. Achieving Shared Goals in Medicine Taking. London: Royal Pharmaceutical Society of Great Britain; 1997;
2. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J. Clin. Pharm. Ther. 2001;26:331–342
   • MEDLINE
   • CrossRef
3. International Diabetes Federation (IDF), 2004, facts and figures available at: http://www.idf.org/home/index.cfm?node=6.
4. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diab. Med. 1997;14(Supp l5):S1–S85
5. Audit Commission, Testing Times: A review of Diabetes Services in England and Wales, London, 2001.
6. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolism control and drug adherence in an indigent population. Diab. Care. 2002;25:1015–1021
7. Kinmonth AL, Griffin S, Wareham NJ. Implications of the United Kingdom prospective diabetes study for general practice care of type 2 diabetes. Br. J. Gen. Pract. 1999;692–694
8. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
   • Abstract
   • Full Text
   • Full-Text PDF (708 KB)
   • CrossRef
9. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854–865
   • Abstract
   • Full Text
   • Full-Text PDF (582 KB)
   • CrossRef
10. UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;314:703–713
11. National Institute of Clinical Excellence, Management of type 2 Diabetes: Blood Glucose (Guideline G), London, NICE, 2002.
12. Krueger RA. Focus Groups: A Practical Guide for Applied Research. Newbury Park, Calif.: Sage Publications; 1988;
13. Vermeire E, Van Royen P, Coenen S, Wens J, Denekens J. The adherence of type 2 diabetes patients to their therapeutic regimen: a qualitative study from the patient's perspective. Pract. Diab. Int. 2003;20(6):209–214
14. European General Practice Research Network, available at http://www.egprn.org/info.htm.
15. Creswell JW. Qualitative Inquiry and Research Design. Thousand Oaks, California: Sage; 1988;
16. D. Petek, Attitudes and adherence to treatment of patients with diabetes mellitus, master's thesis, University of Ljubljana, Slovenia, 2004.
17. Rätsep A. Teist tüüpi diabeediga haitege ravikuulekust mojutavad parsiendipoosed tegurid—kwalitatiivne uuring. Eesti Arst. 2003;5:353–356
18. Vinter-Repalust N, Petriček G, Milica K. Obstacles which patients with type 2 diabetes meet while adhering to the therapeutic regimen in everyday life: qualitative study. Croat. Med. J. 2004;45(5):630–638
    • MEDLINE
19. Noblit GW, Hare RD. Meta-Ethnography: Synthesising Qualitative Studies. Newbury Park: Sage; 1988;
20. Paterson B. Myth of empowerment in chronic illness. J. Adv. Nurs. 2001;574–581
21. Britten N, Campbell R, Pope C, Donovan J, Morgan M, Pill R. Using meta-ethnography to synthesise qualitative research: a worked example. J. Health Serv. Res. Pol. 2002;7(4):209–215
22. Campbell P, Pound P, Pope C, Britten N, Pill R, Morgan M, et al. Evaluating meta-ethnography: a synthesis of qualitative research on lay experiences of diabetes care. Soc. Sci. Med. 2003;56:671–684
    • MEDLINE
    • CrossRef
23. E. Vermeire, The study of research evidence synthesis, applied to adherence to treatment recommendations in people living with type 2 diabetes, Doctoral thesis, Faculty of Medicine, University of Antwerp, Belgium, 2005.
24. Bury M. Chronic illness as a biographical disruption. Sociol. Health Illness. 1982;IV(2):
25. Blaxter M. The causes of disease: women talking. Soc. Sci. Med. 1983;18:59–69
    • MEDLINE
    • CrossRef
26. Barber N, Parsons J, Clofford S, Darracott R, Horne R. Differences in treatment regimes, consultation frequency and referral patters of diabetes mellitus in general practice in five European countries. Fam. Pract. 2004;21:362–369
27. E. Goffman, Les rites d‘ interaction, Paris: Les Editions de Minuit, 1998.
28. Bandura A. Self-efficacy: toward a unifying theory of behavioural change. Psych. Rev. 1977;84:191–215
29. Sandelowski M, Barroso J. Toward a meta-synthesis of qualitative findings on motherhood in HIV-positive women. Res. Nurs. Health. 2003;26(2):153–170
    • MEDLINE
    • CrossRef
30. Sandelowski M, Docherty S, Emden C. Qualitative metasynthesis: issues and techniques. Res. Nurs. Health. 1997;20:365–371
    • MEDLINE
    • CrossRef
31. Donovan JL. Patient decision making. The missing ingredient in compliance research. Int. J. Technol. Assess. Health Care. 1995;11:443–455
    • MEDLINE
    • CrossRef
32. Morris LS, Schulz RM. Patient compliance: an overview. J. Clin. Pharm. Ther. 1992;17:283–295
    • MEDLINE
    • CrossRef
33. Golin CE, DiMatteo MR, Gelberg L. The role of patient participation in the doctor visit. Implications for adherence to diabetes care. Diab. Care. 1996;19:1153–1164
34. McCord EC, Brandenburg C. Beliefs and attitudes of persons with diabetes. Fam. Med. 1995;27:267–271
    • MEDLINE
35. Paterson BL, Sloan J. A phenomenological study of the decision-making experience of individuals with long-standing diabetes. Can. J. Diab. Care. 1994;18:10–19
36. Walsh S, Hagan T, Gamsu D. Rescuer and rescued: applying a cognitive analytical perspective to explore the ‘mis-management’ of asthma. Br. J. Med. Psych. 2000;73:151–168